Skip to main content
. 2023 Apr 13;46(8):zsad103. doi: 10.1093/sleep/zsad103

Figure 1.

Figure 1.

Flow of patients through the trial of sodium oxybate in treatment-resistant rem sleep behavior disorder. Two patients receiving sodium oxybate withdrew from the study during the titration period due to dizziness and severe anxiety. No placebo-treated patients discontinued study drug.